BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 17937839)

  • 1. Future relevance of genetic testing: a systematic horizon scanning analysis.
    Storz P; Kolpatzik K; Perleth M; Klein S; Häussler B
    Int J Technol Assess Health Care; 2007; 23(4):495-504. PubMed ID: 17937839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A content analysis of Health Technology Assessment programs in Latin America.
    Arellano LE; Reza M; Blasco JA; Andradas E
    Int J Technol Assess Health Care; 2009 Oct; 25(4):570-6. PubMed ID: 19845988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
    EFSA GMO Panel Working Group on Animal Feeding Trials
    Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methodology of constructive technology assessment in health care.
    Douma KF; Karsenberg K; Hummel MJ; Bueno-de-Mesquita JM; van Harten WH
    Int J Technol Assess Health Care; 2007; 23(2):162-8. PubMed ID: 17493301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Health technology assessment agencies: an international overview of organizational aspects.
    Martelli F; La Torre G; Di Ghionno E; Staniscia T; Neroni M; Cicchetti A; Von Bremen K; Ricciardi W;
    Int J Technol Assess Health Care; 2007; 23(4):414-24. PubMed ID: 17937828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation criteria to assess the value of identification sources for horizon scanning.
    Smith J; Cook A; Packer C
    Int J Technol Assess Health Care; 2010 Jul; 26(3):348-53. PubMed ID: 20584366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of the Internet in scanning the horizon for new and emerging health technologies: a survey of agencies involved in horizon scanning.
    Douw K; Vondeling H; Eskildsen D; Simpson S
    J Med Internet Res; 2003; 5(1):e6. PubMed ID: 12746211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of genome research on children and their families.
    Williams JK
    J Pediatr Nurs; 2000 Aug; 15(4):207-11. PubMed ID: 10969492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Making processes reliable: a validated pubmed search strategy for identifying new or emerging technologies.
    Varela-Lema L; Punal-Riobóo J; Acción BC; Ruano-Ravina A; García ML
    Int J Technol Assess Health Care; 2012 Oct; 28(4):452-9. PubMed ID: 22995101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Economic evaluations conducted by Canadian health technology assessment agencies: where do we stand?
    Tarride JE; McCarron CE; Lim M; Bowen JM; Blackhouse G; Hopkins R; O'Reilly D; Xie F; Goeree R
    Int J Technol Assess Health Care; 2008; 24(4):437-44. PubMed ID: 18828938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Procedures and methods of benefit assessments for medicines in Germany.
    Bekkering GE; Kleijnen J
    Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surrogate outcomes in health technology assessment: an international comparison.
    Velasco Garrido M; Mangiapane S
    Int J Technol Assess Health Care; 2009 Jul; 25(3):315-22. PubMed ID: 19619350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Procedures and methods of benefit assessments for medicines in Germany].
    Bekkering GE; Kleijnen J
    Dtsch Med Wochenschr; 2008 Dec; 133 Suppl 7():S225-46. PubMed ID: 19034813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current impact of gene technology on healthcare. A map of economic assessments.
    Rogowski W
    Health Policy; 2007 Feb; 80(2):340-57. PubMed ID: 16678930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Historical development of health technology assessment in Thailand.
    Teerawattananon Y; Tantivess S; Yothasamut J; Kingkaew P; Chaisiri K
    Int J Technol Assess Health Care; 2009 Jul; 25 Suppl 1():241-52. PubMed ID: 19527543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences in the identification process for new and emerging health technologies: analysis of the EuroScan database.
    Ibargoyen-Roteta N; Gutierrez-Ibarluzea I; Benguria-Arrate G; Galnares-Cordero L; Asua J
    Int J Technol Assess Health Care; 2009 Jul; 25(3):367-73. PubMed ID: 19619356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biomedical literature search protocols: consensus statement from the documentation units of the Spanish health technology assessment agencies.
    Guemes-Careaga I; Gutiérrez-Ibarluzea I
    Int J Technol Assess Health Care; 2008; 24(1):104-11. PubMed ID: 18218175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EuroGentest: DNA-based testing for heritable disorders in Europe.
    Javaher P; Kaariainen H; Kristoffersson U; Nippert I; Sequeiros J; Zimmern R; Schmidtke J
    Community Genet; 2008; 11(2):75-120. PubMed ID: 18204250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A short history of health technology assessment in Germany.
    Perleth M; Gibis B; Göhlen B
    Int J Technol Assess Health Care; 2009 Jul; 25 Suppl 1():112-9. PubMed ID: 19500440
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emerging trends in genetic-based medical diagnostics.
    Robinson K
    Clin Leadersh Manag Rev; 2005 May; 19(3):E2. PubMed ID: 15927094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.